Oliver Rausch
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and WNT pathway activation.
Journal: bioRxiv : the preprint server for biology
Published: March 10, 2025
RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and Wnt pathway activation.
Journal: Blood
Published: November 27, 2024
Author Correction: RNA stability controlled by m6A methylation contributes to X-to-autosome dosage compensation in mammals.
Journal: Nature structural & molecular biology
Published: July 06, 2023
Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages.
Journal: Leukemia
Published: April 06, 2023
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity.
Journal: Cancer discovery
Published: January 03, 2023
RNA stability controlled by m6A methylation contributes to X-to-autosome dosage compensation in mammals.
Journal: Nature structural & molecular biology
Published: October 19, 2022
Predicting genes associated with RNA methylation pathways using machine learning.
Journal: Communications biology
Published: January 10, 2022
Deep and accurate detection of m6A RNA modifications using miCLIP2 and m6Aboost machine learning.
Journal: Nucleic acids research
Published: January 13, 2021
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.
Journal: Nature
Published: December 18, 2020
RNA-modifying enzymes and their function in a chromatin context.
Journal: Nature structural & molecular biology
Published: July 04, 2019
CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis Model.
Journal: ACS medicinal chemistry letters
Published: April 08, 2016
Localizing the lipid products of PI3Kγ in neutrophils.
Journal: Advances in biological regulation
Published: October 02, 2015
Last Updated: 09/26/2026